References
- Balfour, J. A. and L. R. Wiseman. 1999. Moxifloxacin. Drugs 57: 363-373. https://doi.org/10.2165/00003495-199957030-00007
- Bannoehr, J., A. Franco, M. Iurescia, A. Battisti, and J. R. Fitzgerald. 2009. Molecular diagnostic identification of Staphylococcus pseudintermedius. J. Clin. Microbiol. 47: 469-471. https://doi.org/10.1128/JCM.01915-08
- Bisognano, C., P. Vaudaux, P. Rohner, D. P. Lew, and D. C. Hooper. 2000. Induction of fibronectin-binding proteins and increased adhesion of quinolone-resistant Staphylococcus aureus by subinhibitory levels of ciprofloxacin. Antimicrob. Agents Chemother. 44: 1428-1437. https://doi.org/10.1128/AAC.44.6.1428-1437.2000
- Cohn, L. A., A. T. Gary, W. H. Fales, and R. W. Madsen. 2003. Trends in fluoroquinolone resistance of bacteria isolated from canine urinary tracts. J. Vet. Diagn. Invest. 15: 338-343. https://doi.org/10.1177/104063870301500406
- Devriese, L. A., M. Vancanneyt, M. Baele, M. Vaneechoutte, E. De Graef, C. Snauwaert, et al. 2005. Staphylococcus pseudintermedius sp. nov., a coagulase-positive species from animals. Int. J. Syst. Evol. Microbiol. 55: 1569-1573. https://doi.org/10.1099/ijs.0.63413-0
- Ganiere, J. P., C. Medaille, and C. Mangion. 2005. Antimicrobial drug susceptibility of Staphylococcus intermedius Clinical isolates from canine pyoderma. J. Vet. Med. B 52: 25-31. https://doi.org/10.1111/j.1439-0450.2004.00816.x
- Gottlieb, S., D. Wigney, P. Martin, J. Norris, R. Malik, and M. Govendir. 2008. Susceptibility of canine and feline Escherichia coli and canine Staphylococcus intermedius isolates to fluoroquinolones. Aust. Vet. J. 86: 147-152. https://doi.org/10.1111/j.1751-0813.2008.00270.x
- Hoekstra, K. A. and R. J. Paulton. 1996. Antibiotic sensitivity of Staphylococcus aureus and Staph. intermedius of canine and feline origin. Lett. Appl. Microbiol. 22: 192-194. https://doi.org/10.1111/j.1472-765X.1996.tb01140.x
- Ihrke, P., M. Papich, and T. Demanuelle. 1999. The use of fluoroquinolones in veterinary dermatology. Vet. Dermatol. 10: 193-204. https://doi.org/10.1046/j.1365-3164.1999.00179.x
- Intorre, L., M. Vanni, D. Di Bello, C. Pretti, V. Meucci, R. Tognetti, G. Soldani, G. Cardini, and O. Jousson. 2007. Antimicrobial susceptibility and mechanism of resistance to fluoroquinolones in Staphylococcus intermedius and Staphylococcus schleiferi. J. Vet. Pharmacol. Ther. 30: 464-469. https://doi.org/10.1111/j.1365-2885.2007.00896.x
- Jones, R. D., S. A. Kania, B. W. Rohrbach, L. A. Frank, and D. A. Bemis. 2007. Prevalence of oxacillin- and multidrug-resistant staphylococci in clinical samples from dogs: 1,772 samples (2001-2005). J. Am. Vet. Med. Assoc. 230: 221-227. https://doi.org/10.2460/javma.230.2.221
- Lee, J. 1994. Staphylococcus intermedius isolated from dog-bite wounds. J. Infect. 29: 105. https://doi.org/10.1016/S0163-4453(94)95276-0
- Lee, K., K. H. Park, S. H. Jeong, H. S. Lim, J. H. Shin, D. Yong, G. Y. Ha, Y. Chong, and K. group. 2006. Further increase of vancomycin-resistant Enterococcus faecium, amikacin- and fluoroquinolone-resistant Klebsiella pneumoniae, and imipenem-resistant Acinetobacter spp. in Korea: 2003 KONSAR surveillance. Yonsei Med. J. 47: 43-54. https://doi.org/10.3349/ymj.2006.47.1.43
- Lee, Y. J., J. K. Cho, K. S. Kim, R. B. Tak, A. R. Kim, J. W. Kim, S. K. Im, and B. H. Kim. 2005. Fluoroquinolone resistance and gyrA and parC mutations of Escherichia coli isolated from chicken. J. Microbiol. 43: 391-397.
- Lloyd, D., A. Lamport, W. Noble, and S. Howell. 1999. Fluoroquinolone resistance in Staphylococcus intermedius. Vet. Dermatol. 10: 249-251. https://doi.org/10.1046/j.1365-3164.1999.00187.x
- Loeffler, A., M. Linek, A. Moodley, L. Guardabassi, J. Sung, M. Winkler, R. Weiss, and D. Lloyd. 2007. First report of multiresistant, mecA-positive Staphylococcus intermedius in Europe: 12 cases from a veterinary dermatology referral clinic in Germany. Vet. Dermatol. 18: 412-421. https://doi.org/10.1111/j.1365-3164.2007.00635.x
- Lyskova, P., M. Vydrzalova, and J. Mazurova. 2007. Identification and antimicrobial susceptibility of bacteria and yeasts isolated from healthy dogs and dogs with otitis externa. J. Vet. Med. A Physiol. Pathol. Clin. Med. 54: 559-563. https://doi.org/10.1111/j.1439-0442.2007.00996.x
- NCCLS. 2008. Performance Standards for Antimicrobial Disk and Dilution Susceptibility Tests for Bacteria Isolated from Animals; Approved standard. CLSI document M31-A3. NCCLS, Wayne, PA.
- NCCLS. 2009. Performance Standards for Antimicrobial Susceptibility Testing, Nineteenth Informational Supplement. CLSI document M100-S19 NCCLS, Wayne, PA.
- Pedersen, K., H. Jensen, K. Finster, V. F. Jensen, and O. E. Heuer. 2007. Occurrence of antimicrobial resistance in bacteria from diagnostic samples from dogs. J. Antimicrob. Chemother. 60: 775-781. https://doi.org/10.1093/jac/dkm269
- Pellerin, J. L., P. Bourdeau, H. Sebbag, and J. M. Person. 1998. Epidemiosurveillance of antimicrobial compound resistance of Staphylococcus intermedius clinical isolates from canine pyodermas. Comp. Immunol. Microbiol. Infect. Dis. 21: 115-133. https://doi.org/10.1016/S0147-9571(97)00026-X
- Ruiz, J. 2003. Mechanisms of resistance to quinolones: Target alterations, decreased accumulation and DNA gyrase protection. J. Antimicrob. Chemother. 51: 1109-1117. https://doi.org/10.1093/jac/dkg222
- Ruscher, C., A. Lubke-Becker, C. G. Wleklinski, A. Soba, L. H. Wieler, and B. Walther. 2009. Prevalence of methicillin-resistant Staphylococcus pseudintermedius isolated from clinical samples of companion animals and equidaes. Vet. Microbiol. 136: 197-201. https://doi.org/10.1016/j.vetmic.2008.10.023
- Shimizu, A., Y. Wakita, S. Nagase, M. Okabe, T. Koji, T. Hayashi, et al. 2001. Antimicrobial susceptibility of Staphylococcus intermedius isolated from healthy and diseased dogs. J. Vet. Med. Sci. 63: 357-360. https://doi.org/10.1292/jvms.63.357
- Tanner, M. A., C. L. Everett, and D. C. Youvan. 2000. Molecular phylogenetic evidence for noninvasive zoonotic transmission of Staphylococcus intermedius from a canine pet to a human. J. Clin. Microbiol. 38: 1628-1631.
- Van Hoovels, L., A. Vankeerberghen, A. Boel, K. Van Vaerenbergh, and H. De Beenhouwer. 2006. First case of Staphylococcus pseudintermedius infection in a human. J. Clin. Microbiol. 44: 4609-4612. https://doi.org/10.1128/JCM.01308-06
- Venezia, R. A., B. E. Domaracki, A. M. Evans, K. E. Preston, and E. M. Graffunder. 2001. Selection of high-level oxacillin resistance in heteroresistant Staphylococcus aureus by fluoroquinolone exposure. J. Antimicrob. Chemother. 48: 375-381. https://doi.org/10.1093/jac/48.3.375
- Weber, S. G., H. S. Gold, D. C. Hooper, A. W. Karchmer, and Y. Carmeli. 2003. Fluoroquinolones and the risk for methicillin-resistant Staphylococcus aureus in hospitalized patients. Emerg. Infect. Dis. 9: 1415-1422. https://doi.org/10.3201/eid0911.030284
- Zubeir, I. E., T. Kanbar, J. Alber, C. Lammler, O. Akineden, R. Weiss, and M. Zschock. 2007. Phenotypic and genotypic characteristics of methicillin/oxacillin-resistant Staphylococcus intermedius isolated from clinical specimens during routine veterinary microbiological examinations. Vet. Microbiol. 121: 170-176. https://doi.org/10.1016/j.vetmic.2006.11.014
Cited by
- Antibiotic Resistance Profiles of Staphylococcus pseudintermedius Isolates from Canine Patients in Korea vol.20, pp.12, 2010, https://doi.org/10.4014/jmb.1001.01011
- Determination of staphylococcal exotoxins, SCC mec types, and genetic relatedness of Staphylococcus intermedius group isolates from veterinary staff, companion animals, and hospital environments in vol.12, pp.3, 2010, https://doi.org/10.4142/jvs.2011.12.3.221
- Methicillin‐resistant Staphylococcus pseudintermedius isolated from canine pyoderma in North China vol.112, pp.4, 2012, https://doi.org/10.1111/j.1365-2672.2012.05233.x
- Antimicrobial resistance of Staphylococcus pseudintermedius isolates from healthy dogs and dogs affected with pyoderma in Japan vol.23, pp.1, 2010, https://doi.org/10.1111/j.1365-3164.2011.00995.x
- Comparative mutant prevention concentration and mechanism of resistance to veterinary fluoroquinolones in Staphylococcus pseudintermedius vol.23, pp.4, 2010, https://doi.org/10.1111/j.1365-3164.2012.01038.x
- High prevalence of Enterococcus spp. from dogs with otitis externa vol.35, pp.2, 2010, https://doi.org/10.7853/kjvs.2012.35.2.099
- Prevalence of and risk factors for isolation of meticillin‐resistant Staphylococcus spp. from dogs with pyoderma in northern California, USA vol.24, pp.1, 2013, https://doi.org/10.1111/j.1365-3164.2012.01051.x
- Misuse of Antimicrobials and Selection of Methicillin‐Resistant Staphylococcus pseudintermedius Strains in Breeding Kennels: Genetic Characterization of Bacteria After a Two‐year Interval vol.48, pp.1, 2010, https://doi.org/10.1111/j.1439-0531.2012.02012.x
- Prevalence and risk factors for carriage of multi-drug resistant Staphylococci in healthy cats and dogs vol.14, pp.4, 2010, https://doi.org/10.4142/jvs.2013.14.4.449
- Antibiotic resistance and molecular characterization of ophthalmic Staphylococcus pseudintermedius isolates from dogs vol.15, pp.3, 2014, https://doi.org/10.4142/jvs.2014.15.3.409
- A Bioengineered Nisin Derivative to Control Biofilms of Staphylococcus pseudintermedius vol.10, pp.3, 2010, https://doi.org/10.1371/journal.pone.0119684
- Review: Pathogenesis of canine atopic dermatitis: skin barrier and host–micro‐organism interaction vol.26, pp.2, 2010, https://doi.org/10.1111/vde.12197
- Emergence of biofilm-producingStaphylococcus pseudintermediusisolated from healthy dogs in South Korea vol.35, pp.4, 2010, https://doi.org/10.1080/01652176.2015.1096429
- In Vitro Activities of Nisin and Nisin Derivatives Alone and In Combination with Antibiotics against Staphylococcus Biofilms vol.7, pp.None, 2010, https://doi.org/10.3389/fmicb.2016.00508
- Prevalence and risk factors of Staphylococcus spp. carriage among dogs and their owners: A cross-sectional study vol.212, pp.None, 2010, https://doi.org/10.1016/j.tvjl.2015.10.059
- 개와 고양이에서 분리한 methicillin 내성 및 감수성 Staphylococcus pseudintermedius vol.39, pp.3, 2010, https://doi.org/10.7853/kjvs.2016.39.3.175
- Concurrent development of generalised demodicosis, dermatophytosis and meticillin-resistant Staphylococcus pseudintermedius secondary to inappropriate treatment of atopic dermatitis in an adult dog vol.5, pp.1, 2010, https://doi.org/10.1136/vetreccr-2017-000426
- 대구지역 개와 고양이에서 분리된 Staphylococcus pseudintermedius의 fluoroquinolone 내성 vol.40, pp.1, 2010, https://doi.org/10.7853/kjvs.2017.40.1.41
- Molecular characteristics of new clonal complexes of Staphylococcus pseudintermedius from clinically normal dogs vol.38, pp.1, 2018, https://doi.org/10.1080/01652176.2017.1400710
- 경북지역 개와 고양이에서 methicillin-resistant Staphylococcus. pseudintermedius (MRSP) 검출률 조사 vol.41, pp.4, 2010, https://doi.org/10.7853/kjvs.2018.41.4.229
- Carriage of Staphylococcus schleiferi from canine otitis externa: antimicrobial resistance profiles and virulence factors associated with skin infection vol.20, pp.2, 2010, https://doi.org/10.4142/jvs.2019.20.e6
- 인천지역 반려견 유래 세균의 항생제 내성 모니터링 조사 vol.42, pp.2, 2010, https://doi.org/10.7853/kjvs.2019.42.2.53
- Multidrug resistance of coagulase-negative staphylococci isolated from rescued wild animals vol.42, pp.4, 2010, https://doi.org/10.7853/kjvs.2019.42.4.251
- Photodynamic Therapy Using Topically Applied 5-ALA, MAL and CLC for Canine Otitis Externa vol.37, pp.1, 2010, https://doi.org/10.17555/jvc.2020.02.37.1.1
- Oral Plus Topical Administration of Enrofloxacin-Hydrochloride-Dihydrate for the Treatment of Unresponsive Canine Pyoderma. A Clinical Trial vol.10, pp.6, 2010, https://doi.org/10.3390/ani10060943
- Antimicrobial Resistance of Coagulase-Positive Staphylococcus Isolates Recovered in a Veterinary University Hospital vol.9, pp.11, 2010, https://doi.org/10.3390/antibiotics9110752
- The Complex Diseases of Staphylococcus pseudintermedius in Canines: Where to Next? vol.8, pp.1, 2010, https://doi.org/10.3390/vetsci8010011
- Application of Topical Madecassoside Cream in Dogs and Cats with Skin Diseases vol.38, pp.2, 2010, https://doi.org/10.17555/jvc.2021.04.38.2.56